Lili Tong

Lili Tong

Auto-generated profile, based on publicly available information

Lili Tong

School of Earth Science and Resources Chang'an University Xi'an China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2018 in Geological Journal
Verified
Journal Article
Closed access
PDF file
GYGaoxue Yang
Gaoxue Yang
YLYongjun Li
Yongjun Li
SLSanzhong Li
Sanzhong Li
LTLili Tong
Lili Tong
ZWZuopeng Wang
Zuopeng Wang
LWLe Wu
Le Wu



25 July 2018 in Geological Journal
Verified
Journal Article
Closed access
PDF file
YLYongjun Li
Yongjun Li
QXQian Xu
Qian Xu
GYGaoxue Yang
Gaoxue Yang
RWRan Wang
Ran Wang
LTLili Tong
Lili Tong
ZWZhenyu Wang
Zhenyu Wang

8 December 2017 in Geological Journal
Verified
Journal Article
Closed access
PDF file
GYGaoxue Yang
Gaoxue Yang
YLYongjun Li
Yongjun Li
LTLili Tong
Lili Tong
ZWZuopeng Wang
Zuopeng Wang
QXQian Xu
Qian Xu

23 December 2022 in Advanced Healthcare Materials
Verified
Journal Article
Open access
MJMeiling Jin
Meiling Jin
JHJingchu Hu
Jingchu Hu
LTLili Tong
Lili Tong
BZBao-zhong Zhang
Bao-zhong Zhang
JHJIANDONG HUANG
JIANDONG HUANG
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) share many cellular and molecular features with cancer cells. Taking advantage of these similarities, stem cells are effective vaccines against cancers in animal models. However, the molecular basis is not well understood, which hinders the development of effective cancer vaccines. Here, prophylactic and therapeutic bladder cancer vaccines composed of allogeneic ESCs and CpG with or without granulocyte macrophage colony stimulating factor are tested. The ESC‐based cancer vaccines are able to induce specific antitumor immunity including stimulating cytotoxic CD8+ T cells and memory CD4+ T cells, reducing myeloid‐derived suppressor cells, and preventing bladder cancer growth in mouse models. Furthermore, several genes that are overexpressed in both ESCs and tumors are identified. An epitope‐based vaccine designed with shared overexpressed proteins induces specific antitumor immunity and reduces bladder cancer growth. Functional epitopes underlying the action of stem cell‐based vaccines against bladder cancer are identified and it is confirmed that ESC‐based anticancer vaccines have great potential. A systematic approach is provided here to developing novel effective epitope‐based cancer vaccines in the future.